A scoping review of pharmacy participation in dental and oral health care

Hu, Jie; McMillan, Sara Sinclair; El-Den, Sarira; O’Reilly, Claire; Collins, J.S.H.; Wheeler, Amanda

doi:10.1111/cdoe.12651

Cited by 7 publications

(11 citation statements)

References 81 publications

(347 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To further inform training development, the research team completed two literature reviews (Hu et al, 2022;Ng et al, 2022) and identified key literature pertaining to physical healthcare (Kisely et al, 2015;Mazoruk et al, 2020;Vancampfort et al, 2018Vancampfort et al, , 2019 and medication adherence (García et al, 2016;MacDonald et al, 2016;Velligan et al, 2017) for people living with SPMI. Acceptability of antipsychotic medication is well-recognised as problematic among this vulnerable population (Wade et al, 2017) with adherence to an issue of concern (Wade et al, 2017;Younas et al, 2016).…”

Section: Resultsmentioning

confidence: 99%

A training programme for community pharmacists to support people living with severe and persistent mental illness: Intervention mapping in the context of a pandemic

McMillan

El-Den

O’Reilly

et al. 2022

Health Education Journal

View full text Add to dashboard Cite

Objective: The Bridging the Gap Between Physical and Mental Illness in Community Pharmacy ( PharMIbridge) randomised controlled trial (RCT) aims to test the effectiveness of a pharmacist-led support service in improving medication adherence, and the physical and mental health of people living with severe and persistent mental illness compared to a standard medication review service. Method: Using the six-step intervention mapping (IM) framework, this paper describes the development and content of the PharMIbridge pharmacist training programme, an integral part of the RCT implementation, and continuous adaptations made to the process to keep pace with the evolving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in Australia. A Training Working Group comprising health educators, practitioners, mental health consumers and researchers, refined the programme objectives and assisted with developing content and troubleshooting issues related to training delivery for pharmacists randomised to the RCT intervention arm. Results: A 2-day training programme was developed, which included Mental Health First Aid, simulated patient role-plays, and four pre-recorded modules using lectures, demonstration case vignettes, role-play activities and discussion. The programme, co-facilitated by project team members and mentors (pharmacist and consumer educators), aims to enhance pharmacists’ mental health literacy, skills and confidence and empower them to engage with this vulnerable population using a strengths-based approach. Pre- and post-training questionnaires and interviews will be used to evaluate the impact of the PharMIbridge training programme. Conclusion: The systematic stepwise method provided by the IM framework highlights the solution-focused approach adopted by the project team and characteristics including adaptability and resilience which enabled training development and implementation across four Australian regions during the SARS-CoV-2 pandemic.

show abstract

Section: Resultsmentioning

confidence: 99%

A training programme for community pharmacists to support people living with severe and persistent mental illness: Intervention mapping in the context of a pandemic

McMillan

El-Den

O’Reilly

et al. 2022

Health Education Journal

View full text Add to dashboard Cite

show abstract

“…6 Pharmacists are among these professionals as they take an active role with their oral health knowledge and behavior. 22 Therefore, it is necessary for pharmacists to acquire and develop information in their undergraduate education. Within the scope of this study, various questions were asked to determine the situation regarding the oral-dental health habits of the pharmacy students.…”

Section: Discussionmentioning

confidence: 99%

“…However, there are limited studies conducted with pharmacy students. [19][20][21][22] Therefore, in this study, it was aimed to evaluate and reveal the oral care habits, awareness and basic knowledge of oral dental health of the pharmacy students.…”

Section: Introductionmentioning

confidence: 99%

Oral Care and Maintenance Habits Among Pharmacy Students

Özler

Dalgara

Şahne

et al. 2023

American Journal of Pharmaceutical Education

View full text Add to dashboard Cite

“…Dental settings with integrated pharmacist-led services have shown improved prescribing practices and use of medication. 21 Pharmacists collaborating with a dentist could lead to improved management of xerostomia as well.…”

Section: Discussionmentioning

confidence: 99%

Medication Use Among Patients Reporting Xerostomia of an Academic Dental Clinic

Krajewski

et al. 2022

Journal of Pharmacy Technology

View full text Add to dashboard Cite

Background: Global prevalence of xerostomia has been reported at 22% (range 0.01%-45%), negatively impacting oral health, nutrition intake, and quality of life. The causal relationship between xerostomia and medications remains uncertain but greater understanding could guide interventions. Objective: To describe the demographic characteristics and medication regimens in patients with xerostomia of an academic dental clinic. Method: This is a retrospective academic dental clinic record review from July 1, 2018 to October 27, 2020. Patient records were obtained from the University at Buffalo, School of Dental Medicine. Xerostomia status was determined via query of electronic health records and validated by manual review. Pharmacologic class and xerostomic potential of medications were identified by the Veterans Affairs Drug Classification System and drug compendia, respectively. Predictors of medication use were assessed using a multiple logistic regression model. Results: Of 37 403 examined records, 366 (0.98%) were identified as xerostomic. After excluding confounding factors (Sjogren’s and radiation), 275 of 317 patients received at least one xerostomic medication, majority were female (240, 66%) versus male (126, 34%). Mean ± (SD) age was 64.9 ± 15.11 years. A total of 208 (57%) patients were aged ≥65. The median number of total and xerostomic medications were 8 (interquartile range [IQR], 4-12) and 4 (IQR, 2-7), respectively. The 3 most prevalent xerostomic pharmacologic classes were antidepressants (131, 35%), gastric medications (101, 28%), and vitamin D (87, 24%). Conclusion: Despite observed prevalence of xerostomia lower than global prevalence, xerostomic medication burden for patients experiencing xerostomia was high. Pharmacist-led interprofessional collaborations should be investigated to reduce xerostomic burden.

show abstract

A scoping review of pharmacy participation in dental and oral health care

Cited by 7 publications

References 81 publications

A training programme for community pharmacists to support people living with severe and persistent mental illness: Intervention mapping in the context of a pandemic

A training programme for community pharmacists to support people living with severe and persistent mental illness: Intervention mapping in the context of a pandemic

Oral Care and Maintenance Habits Among Pharmacy Students

Medication Use Among Patients Reporting Xerostomia of an Academic Dental Clinic

Contact Info

Product

Resources

About